Biggest News Aggregation in the World
📰 Existing Convertible Notes News

Page 2 - Existing Convertible Notes News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Existing Convertible Notes. Real-time updates on events, politics, business and more.

Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027

Share this article Share this article SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), a leader in converting IV biologics to subcutaneous delivery, today announced the pricing of $700 million aggregate principal amount of its convertible senior notes due 2027 (the "Convertible Notes"). The Convertible Notes are being offered in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act ...
San Diego United States Al Kildani Bristol Myers Squibb Exchange Commission Company Annual Report On Form

Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2027

Share this article Share this article SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), a leader in converting IV biologics to subcutaneous delivery, today announced that it intends to offer, subject to market conditions and other factors, $500 million aggregate principal amount of convertible senior notes due 2027 (the "Convertible Notes"). The Convertible Notes are to be offered and sold to "qualified institutional buyers" purs...
San Diego United States Al Kildani Bristol Myers Squibb Stock Repurchase Program Halozyme Therapeutics Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science